Mark Guthridge

EXPERTISE: The molecular and cellular biology of cancer cells; cytokine and growth factor biology; intracellular signalling; drug discovery; translational research; preclinical models of cancer; Haematology; Blood diseases.

RESEARCH INTERESTS: Dr. Guthridge is currently an NH&MRC Senior Research Fellow (SRF) at Monash University, Australia where he heads the Leukemia Research Laboratory. His research focuses on the mechanisms underpinning malignant transformation and the identification of new therapeutic targets. His laboratory has developed a range of model systems that allows the testing and preclinical development of novel drug therapies for the treatment of cancers such as leukemia.

TRACK RECORD OF RESEARCH AND DISCOVERY: Dr. Guthridge has an established international profile in cancer research and receives regular invitations to present his work at National and International conferences. He has received funding from International (NIH, AICR), National (NH&MRC, LFA, Cancer Council of SA). His work has been published in leading scientific journals including Cell, Molecular Cell, Cell Stem Cell and EMBO J, Blood, Leukemia and Cancer Research.

CONTRIBUTIONS TO THE RESEARCH COMMUNITY: Dr. Guthridge regularly serves on grant review committees for the NH&MRC (Immunology, Haematology and Cancer Biology), Cancer Australia, the AICR and the Leukaemia Foundation of Australia. He serves on the Editorial Boards for several international peer-reviewed journals. He has also served as co-convener of the New Directions in Leukaemia Research (NDLR) Meetings and on the Scientific Committee of the Science Amongst the Vines Signalling meetings.

TRACK RECORD IN EDUCATION: Dr. Guthridge teaches both undergraduate and postgraduate students providing lectures, workshops, and practicals. In addition to supervising Honors and Ph.D students, he also regularly takes on undergraduate students seeking laboratory placements in order to gain hands-on research experience.